Transforming growth factor-β1 enhances the lethal effects of DNA- damaging agents in a human lung-cancer cell line

International Journal of Cancer

Volumn 72, Issue 2, 1997, Pages 356-361

  Raynal, Stéphane ^a   Nocentini, Silvano ^b   Croisy, Alain ^b   Lawrence, David A ^b   Jullien, Pierre ^b  

^a Institute de Recherche sur le Cancer   (France)

^b INSTITUT CURIE   (France)

Author keywords

[No Author keywords available]

Indexed keywords

BOVINE SERUM ALBUMIN; CISPLATIN; FLUOROURACIL; METHOTREXATE; PROTEIN P53; PYRIMIDINE DIMER; RECOMBINANT TRANSFORMING GROWTH FACTOR BETA1;

ANIMAL CELL; ARTICLE; CANCER CELL CULTURE; CELL KILLING; CLONOGENESIS; CONTROLLED STUDY; DNA DAMAGE; DRUG EFFECT; DRUG POTENTIATION; EXCISION REPAIR; GAMMA RADIATION; HUMAN; HUMAN CELL; IMMUNOPRECIPITATION; LETHALITY; LUNG CANCER; MINK; NONHUMAN; PRIORITY JOURNAL;

ANIMALS; ANTINEOPLASTIC AGENTS; CELL DEATH; CISPLATIN; DNA DAMAGE; DRUG SYNERGISM; FLUOROURACIL; HUMANS; LUNG NEOPLASMS; METHOTREXATE; TRANSFORMING GROWTH FACTOR BETA; TUMOR CELLS, CULTURED;

EID: 0030747797     PISSN: 00207136     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1097-0215(19970717)72:2<356::AID-IJC26>3.0.CO;2-C     Document Type: Article

References (26)

1. ALEXANDROW, M.G. and MOSES, H.L., Transforming growth factor-β and cell cycle regulation. Cancer Res., 55, 1452-1457 (1995).
2. ARMSTRONG, D.K., ISAAC, J.T., OTTAVIANO, Y.L. and DAVIDSON, N.E., Programmed cell death in a estrogen-independent human cancer cell line, MDA-MB-468. Cancer Res., 52, 3418-3424 (1992).
3. BARCELLOS-HOFF, M.H., DERYNCK, R., TSANG, M.L.S. and WEATHERBEE, J.A., Transforming growth factor-β activation in irradiated murine mammary gland. J. clin. Invest., 93, 892-899 (1994).
4. CARR, A.M. and HOEKSTRA, M.F., The cellular response to DNA damage. Trends Cell Biol. 5, 32-40 (1995).
5. DAMON, L.E., CADMAN, E. and BENZ, C., Enhancement of 5-fluorouracil antitumor effects by the prior administration of methotrexate. Pharmacol. Ther., 43, 155-185 (1989).
6. DAVIES, D.R., Repair mechanisms and variations in UV sensitivity within the cell cycle. II. Mutation Res., 2, 477-486 (1965).
7. FRAM, R.J., Cisplatin and platinum analogues: recent advances. Curr. Opin. Oncol., 4, 1073-1079 (1992).
8. FRIEDBERG, E.C., WALKER, G.C. and SIEDE, W., DNA repair and mutagenesis, ASM Press, Washington, DC (1995).
9. GÖTZ, C. and MONTENARH, M., P53: DNA damage, DNA repair and apoptosis. Rev. Physiol. Biochem. Pharmacol., 127, 65-95 (1996).
10. LAWRENCE, D.A., PIRCHER, R. and JULLIEN, P., Normal embryo fibroblasts release transforming growth factors in a latent form. J. cell. Physiol., 121, 184-188 (1984).
11. MARTIKAINEN, P., KYPRIANOU, N. and ISAACS, J.T., Effect of transforming growth factor-β1 on proliferation and death of rat prostatic cells. Endocrinology, 127, 2963-2968 (1990).
12. MASSAGUÉ, J. and POLYAK, K., Mammalian antiproliferative signals and their targets. Curr. Opin. Genet. Develop., 5, 91-96 (1995).
13. MCKENZIE, R.C., PARK, E.S., BROWN, W.R., SHIVJI, G.S. and SAUDER, D.N., Effect of ultraviolet-inducible cytokines on melanoma growth in vivo: stimulation of melanoma growth by interleukin-1 and -6. Photoderm. Photoimmun. Photomed., 10, 74-79 (1994).
14. MIYAZONO, K., HICHIJO, H. and HELDIN, C.-H., A role of the latent TGF-β1 binding protein in the assembly and secretion of TGF-β1. EMBO J., 10, 1091-1101 (1991).
15. NOCENTINI, S., Comet assay analysis of repair of DNA strand breaks in normal and deficient human cells exposed to radiations and chemicals. Evidence for a repair pathway specificity of DNA ligation. Radiat. Res., 144, 170-180 (1995).
16. PICKSLEY, S.M. and LANE, D.P., P53 and Rb: their cellular roles. Curr. Opin. Cell Biol., 6, 853-856 (1994).
17. PUCK, T.T. and MARCUS, P.I., Action of X-rays on mammalian cells. J. exp. Med., 103, 653-659 (1956).
18. RAYNAL, S., JULLIEN, P. and LAWRENCE, D.A., Transforming growth factor-β1 enhances serum-induced dephosphorylation of the P53 protein in cell lines growth-inhibited by this factor. Growth Factors, 11, 197-203 (1994).
19. RIGGINS, G.J., THIAGALINGAM, S., ROZENBLUM, E., WEINSTEIN, C.L., KERN, S.E., HAMILTON, S.R., WILLSON, J.K.V., MARKOVITZ, S.D., KINZLER, K.W. and VOGELSTEIN, B., Mad-related genes in the human. Nature (Genet.), 13, 347-349 (1996).
20. ROBERTS, A.B. and SPORN, M.B., The transforming growth factor-betas. In: M.B. Sporn and A.B. Roberts (eds.), Handbook of experimental pharmacolocy, vol. 95, I. Peptide growth factors and their receptors, pp. 419-472, Springer-Verlag, Berlin (1990).
21. RÖSL, F., A simple and rapid method for detection of apoptosis in human cells. Nucleic Acids Res., 20, 5243 (1992).
22. SINCLAIR, W.K., Cyclic X-ray sensitivity during the cell generation cycle of cultured Chinese hamster cells. Radiat. Res., 33, 620-643 (1968).
23. SINGH, N.P., MCCOY, M.T., TICE, R.R. and SCHNEIDER, E.L., A simple technique for quantification of low levels of DNA damage in individual cells. Exp. Cell Res., 175, 184-191 (1988).
24. TUCKER, R.F., SHIPLEY, G.D., MOSES, H.L. and HOLLEY, R.W., Growth inhibitor from BSC-1 cells closely related to the platelet type β transforming growth factor. Science, 226, 705-707 (1984).
25. WAKEFIELD, L.M., SMITH, D.M., MASUI, T., HARRIS, C.C. and SPORN, M.B., Distribution and modulation of the cellular receptor for transforming growth factor-beta. J. Cell Biol., 105, 965-975 (1987).
26. WURZER, J.C., TALLARIDA, R.J. and SIROVER, M.A., New mechanism of action of the cancer chemotherapeutic agent 5-fluorouracil in human cells. J. Pharm. exp. Ther., 269, 39-43 (1994).